reduce basal insulin dose when starting glp-1 receptor agonist Adjusting Your Pump a Medication GLP-1 receptor agonists and beyond.

Individual results may vary

In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust your workout routine when taking a GLP-1.

For health-conscious individuals, supplements arent shortcuts, theyre strategic additions

Frequently asked questions

Providers on our platform can now send prescriptions for Zepbound vials and KwikPen, as well as Foundayo, to the LillyDirect pharmacy and access self-pay pricing for Hims & Hers customers.